+97.1%
GSK vs IONS
-41.2%
+138.2%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | IONS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -2.4% | +2.2% | +0.1% |
| 7D | -5.3% | -8.5% | +3.2% | -4.5% |
| 30D | -3.7% | -40.0% | +36.3% | +1.0% |
| 3M | -7.3% | -54.8% | +47.5% | 0.0% |
| 6M | -4.2% | -64.6% | +60.3% | +5.4% |
| YTD | +0.9% | -66.4% | +67.3% | +11.5% |
| 1Y | +7.3% | -63.6% | +70.9% | +17.6% |
| 3Y | +52.7% | -46.5% | +99.2% | +57.5% |
| 5Y | +40.1% | -16.9% | +57.0% | +35.4% |
| All | +97.1% | -41.2% | +138.2% | +92.8% |
Cumulative growth
Daily Returns
Daily percentage return beside IONS.
Daily Out/Under-Performance
Portfolio return minus IONS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IONS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded IONS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling